Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias-Reference-Cited by-同舟云学术

Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias

Published:2001-07 Issue:1 Volume:114 Page:11-24
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Lowdell Mark W.,Lamb Lawrence,Hoyle Christine,Velardi Andrea,Prentice H. Grant

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02906.x/fullpdf

Reference85 articles.

1. Extrathymic T cells stand at an intermediate phylogenetic position between natural killer cells and thymus-derived T cells;Abo;Natural Immunology,1995

2. Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission;Adler;Blood,1988

3. Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and IL2;Anderson;Cancer Immunology Immunotherapy,1988

4. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group;Attal;Blood,1995

5. Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical ‘three loci’ incompatible donors;Aversa;New England Journal of Medicine,1998

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic approaches to enhance natural killer cell cytotoxicity;Frontiers in Immunology;2024-03-11

2. Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA;Immuno;2023-06-20

3. “Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect;Current Treatment Options in Oncology;2023-04-03

4. Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy;Cancers;2023-02-05

5. Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia;Frontiers in Oncology;2023-01-04